Boston Children's Hospital
Boston, Massachusetts, 02446, United States
NCT Number: NCT03192540
This study explores the effects of an eight-week exercise intervention for adolescents with Down syndrome on home exercise compliance. As well, to observe changes in fitness including muscular strength, endurance and aerobic capacity. Finally to observe any changes in mood, behavior and quality of life.
Looking for future studies?
Notify Me10 year–17 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02446, United States
Adolescents with Down syndrome will participate in an eight-week, center-based exercise intervention. Participants will undergo an hour of exercise intervention each week. During this time, participants will be working with a team consisting of a physician, physical therapy student volunteers, and clinical research coordinators. Exercises will focus on strength and endurance of all major muscle groups, while ensuring proper technique and form is used. They will also receive instruction on how to continue the exercise program at home.
Prior to starting, and at the end of eight sessions, all exercise participants will undergo testing procedures for anthropometric, strength and flexibility measurements. This data will be collected as part of clinically evaluating the impact of the program on each participant. In addition to the exercise program (and clinical assessments of fitness), DSFit participants will complete study measures of behavioral functioning as well as scales of depression and anxiety. Participants in the DSFit study will also complete a weekly exercise log during the intervention and for a follow-up period afterwards.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will undergo an exercise protocol once a week, for eight weeks. Exercise will be continuous for one hour.
Time frame: 2 months post completion of the exercise program
To establish if the participant is performing the same amount of exercise each week, for up to three months after the stopped visiting the group exercise sessions.
Time frame: The test will be performed before the exercise intervention and then after 8 weeks of exercise intervention.
Participants will perform body-weight exercises that focus on upper body, lower body, core, and flexibility.
Time frame: The test will be preformed before the exercise intervention and then after 8 weeks of exercise intervention.
Participants will complete the 6 minute walk test, where the investigators will receive an estimate measure of maximum aerobic fitness. Investigators will also collect heart rate and blood pressure as pre and post measurements when possible.
Time frame: The scale will be given the before the exercise intervention begins and then after 8 weeks of exercise intervention.
Patient-Reported Outcomes Measurement Information System (PROMIS) - Parent report questionnaires
Time frame: The scale will be given the before the exercise intervention begins and then after 8 weeks of exercise intervention.
Vanderbilt Scale - parent report questionnaire
Boston Children's Hospital
Other
The Impact of an 8-week Supported Exercise Program on Fitness and Symptoms of Anxiety and Depression in Adolescents With Down Syndrome
Acronym: DSFIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04854122
Abnormalities, Multiple, Behavior
Las Vegas, Nevada, United States
View Trial DetailsNCT03445962
Abnormalities, Multiple, Apnea
Échirolles, France
View Trial DetailsNCT04048759
Abnormalities, Multiple, Alzheimer Disease
Kansas City, Kansas, United States
View Trial DetailsNCT05020366
Abnormalities, Multiple, Behavior
Pittsburgh, Pennsylvania, United States
View Trial Details